Key result
TAVI yields ~10% 30-day mortality in prohibitive surgical risk patients.
Why the study?
Very few data exist on the acute and late outcomes of a comprehensive TAVI program using both TF and TA approaches in patients at very high or prohibitive surgical risk, including inoperable patients with porcelain aorta or frailty.
Does transcatheter aortic valve implantation (TAVI) provide acceptable acute and late outcomes in patients with severe symptomatic aortic stenosis at very high or prohibitive surgical risk?
Cohort (n=339)
Yes
Does transcatheter aortic valve implantation (TAVI) provide acceptable acute and late outcomes in patients with severe symptomatic aortic stenosis at very high or prohibitive surgical risk?
A comprehensive TAVI program including both transfemoral and transapical approaches yields acceptable procedural success and mortality rates in patients with severe aortic stenosis at prohibitive surgical risk.
No takes yet. Share an insight, caveat, or question.
Supports TAVI feasibility in prohibitive-risk patients; leaves open comparative effectiveness and durability versus contemporary therapies.
Rodés‐Cabau et al. (2010) conducted a cohort in Severe symptomatic aortic stenosis at very high or prohibitive surgical risk (n=339). Transcatheter aortic valve implantation (TAVI) was evaluated on 30-day mortality. Transcatheter aortic valve implantation in patients at very high or prohibitive surgical risk achieved a 93.3% procedural success rate and a 10.4% 30-day mortality rate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: